Likewise, the FAK/c-Jun amino terminal kinase (JNK) signaling pathway was shown to prompt the proliferative effects initiated by the tumor-associated antigen Mucin-like 1 (MUCL1) in HER-2 over-expressing breast cancer cells [66]. This evidence concerns the gene ERBB2 and breast cancer.